Results of clinical trial will impact treatment for opioid dependence in Australia and internationally

The results of a clinical trial of extended-release buprenorphine injections (BUP-XR), an opioid agonist treatment (OAT), demonstrate high retention and treatment satisfaction. Led by researchers at the National Drug and Alcohol Research Centre (NDARC), UNSW